Iodohippurate sodium i-123 - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for iodohippurate sodium i-123 and what is the scope of patent protection?
Iodohippurate sodium i-123
is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for iodohippurate sodium i-123
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Patent Applications: | 110 |
DailyMed Link: | iodohippurate sodium i-123 at DailyMed |
US Patents and Regulatory Information for iodohippurate sodium i-123
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | NEPHROFLOW | iodohippurate sodium i-123 | INJECTABLE;INJECTION | 018289-001 | Dec 28, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |